VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke
Status: | Active, not recruiting |
---|---|
Conditions: | Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 30 - 80 |
Updated: | 2/18/2017 |
Start Date: | October 2014 |
End Date: | December 2018 |
Study MT-St-02 - Stroke - A Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function After Stroke (MicroTransponder's Vivistim System)
The primary study objectives are to assess the safety and feasibility of the therapy,
including the surgical intervention and stimulation, as well as to provide information on
the appropriateness of the study test measures (assessments) and to provide a basis for
sample size calculations for a larger, pivotal study.
including the surgical intervention and stimulation, as well as to provide information on
the appropriateness of the study test measures (assessments) and to provide a basis for
sample size calculations for a larger, pivotal study.
Inclusion Criteria:
1. History of ischemic stroke that occurred at least 4 months prior to enrollment, but
not more than 24 months prior
2. Age >30 years and <80 years
3. Right or left sided weakness of upper extremity
4. UEFM score within designated range.
5. At least 10 degrees of wrist extension, 10° of thumb abduction/extension, and at
least 10° of extension in at least 2 additional digits
Exclusion Criteria:
1. History of hemorrhagic stroke
2. Any deficits in language or cognitive functioning that hinders participation, for
example, (aphasia) or unable to follow 2 step commands.
3. Significant sensory loss.
4. Presence of ongoing dysphagia or aspiration difficulties.
5. Active major neurological or psychiatric diagnosis that would likely interfere with
study protocol including prior history of brain lesions (including dementia, etc.),
and current alcohol abuse, drug abuse, or epilepsy.
6. Subject receiving any therapy (medication or otherwise) at study entry that would
interfere with VNS (e.g. drugs that interfere with neurotransmitter mechanisms).
Additionally, no psychoactive medications - including nicotine - may be used during
the acute study.
7. Prior injury to vagus nerve - either bilateral or unilateral (e.g., injury during
carotid endarterectomy)
8. Severe depression
9. Not considered candidate for a device implant surgery (history of adverse reactions
to anesthetics, poor surgical candidate in surgeon's opinion, etc.)
10. Any other implanted device such as a pacemaker or other neurostimulator; any other
investigational device or drug
11. Medical or mental instability (diagnosis of personality disorder, psychosis, or
substance abuse)
12. Pregnant or plan on becoming pregnant or breastfeeding during the study period
13. Currently require, or likely to require, diathermy during the study duration
14. Any health problem requiring surveillance with MRI imaging
15. Active rehabilitation within 4-weeks prior to therapy
16. Botox injections or any other non-study active rehabilitation of the upper extremity
4-weeks prior to and during therapy
17. Severe spasticity of the upper limb
We found this trial at
3
sites
Minneapolis, Minnesota 55455
(612) 625-5000
Principal Investigator: Teresa Kimberley, Ph.D.
Phone: 612-900-8794
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials